Entinostat treatment failed to alter p75NTR protein levels in several mouse organs, such as heart, liver, kidney, and cerebellum, indicating that the drug preferentially targeted neuroblastoma tumors to induce p75NTR. This evidence concerns the gene NGFR and neuroblastoma.